Researchers are using gene editing techniques to introduce beneficial traits like polled and disease resistance, as well as ...

A majority of EU member states have spoken out in favour of less stringent genetic engineering rules, the EU Council ...

Colossal Biosciences, a Dallas-based biotechnology and genetic engineering startup valued at $10 billion, has raised $435 ...

Johns Hopkins scientists say the innovation could bring 'new fruits, foods, and flavors' to an expanded global agricultural ...

Scientists at Colossal Biosciences have achieved a milestone to resurrecting the woolly mammoth: laboratory mice with thick, ...

Colossal Biosciences has focused on identifying key traits of extinct animals by studying ancient DNA, with a goal to genetically "engineer them into living animals," said CEO Ben Lamm.

The team at genetics and biotech firm Colossal Biosciences have imbued rodents with thicker, woolly coats, golden fur and ...

Dallas-based Colossal is one step closer to bringing back the woolly mammoth.

On February 18, 2025, Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications ...

De-extinction company Colossal mixed mammoth and mouse mutations in a single strain to create a shaggy-haired rodent.

Extinction is still forever. But scientists at a biotech company are trying what they say is the next best thing to restoring ...

The company’s name is inspired by the Manhattan Project, according to Emily Mullin of Wired, who spoke with the startup’s ...